Entpd1-deficient mice that were administered B16-F10 mouse melanoma cells and MC-38 mouse colon cancer cells via the hepatic portal vein (experimental metastasis assay) were found to develop significantly fewer hepatic metastases than wildtype (control) mice (Sun et al. 2010). This evidence concerns the gene ENTPD1 and colonic neoplasm.